Bavarian Biotechnology is doing very well
Just published: the Year-2011-survey of the Bavarian Biotechnolgy Industry reveals good progress in employment, pipeline and revenues.
Just published: the Year-2011-survey of the Bavarian Biotechnolgy Industry reveals good progress in employment, pipeline and revenues.
m4-Partner Biomax invites experts from the Munich Biotech Cluster m4 as well as national and European scientists
3rd US-Biotech Company coming to Martinsried within the last 15 month.
Von BioM und TÜV Süd entwickeltes Modulares Lehrgangskonzept: Manager Klinische Entwicklung Pharma & Biotechnologie
Specialist in molecular diagnostic test for personalised medicine starts m⁴ cooperation project with Prof. Berking (LMU) to improve diagnosis and treatment of melanoma patients.
Faster and more accurate: a newly developed alignment-technology outperforming current standard. Published in Nature Methods, 25.12.2011